GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Novoprotein Scientific Co Ltd (SHSE:688137) » Definitions » Price-to-Owner-Earnings

Suzhou Novoprotein Scientific Co (SHSE:688137) Price-to-Owner-Earnings : (As of Jun. 20, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Suzhou Novoprotein Scientific Co Price-to-Owner-Earnings?

As of today (2024-06-20), Suzhou Novoprotein Scientific Co's share price is ¥35.66. Suzhou Novoprotein Scientific Co does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Suzhou Novoprotein Scientific Co's Price-to-Owner-Earnings or its related term are showing as below:


SHSE:688137's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 33.555
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-20), Suzhou Novoprotein Scientific Co's share price is ¥35.66. Suzhou Novoprotein Scientific Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.02. Therefore, Suzhou Novoprotein Scientific Co's PE Ratio for today is At Loss.

As of today (2024-06-20), Suzhou Novoprotein Scientific Co's share price is ¥35.66. Suzhou Novoprotein Scientific Co's EPS without NRI for the trailing twelve months (TTM) ended in was ¥0.35. Therefore, Suzhou Novoprotein Scientific Co's PE Ratio without NRI for today is 102.47.

During the past 6 years, Suzhou Novoprotein Scientific Co's highest PE Ratio without NRI was 134.66. The lowest was 36.48. And the median was 71.38.


Suzhou Novoprotein Scientific Co Price-to-Owner-Earnings Historical Data

The historical data trend for Suzhou Novoprotein Scientific Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Novoprotein Scientific Co Price-to-Owner-Earnings Chart

Suzhou Novoprotein Scientific Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - - -

Suzhou Novoprotein Scientific Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Suzhou Novoprotein Scientific Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, Suzhou Novoprotein Scientific Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Novoprotein Scientific Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Suzhou Novoprotein Scientific Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Suzhou Novoprotein Scientific Co's Price-to-Owner-Earnings falls into.



Suzhou Novoprotein Scientific Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Suzhou Novoprotein Scientific Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=35.66/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Suzhou Novoprotein Scientific Co  (SHSE:688137) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Suzhou Novoprotein Scientific Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Suzhou Novoprotein Scientific Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Novoprotein Scientific Co (SHSE:688137) Business Description

Traded in Other Exchanges
N/A
Address
No. 228, Yunchuang Road, 3rd & 4th Floor, Wujiang Economic and Technological Development Zone, Jiangsu Province, Suzhou, CHN, 215299
Suzhou Novoprotein Scientific Co Ltd is a high-tech enterprise focusing on recombinant protein application solutions. Its main business is the research and development of target and cytokine proteins, recombinant antibodies, enzymes and reagents, Production and sales, and provide related technical services.

Suzhou Novoprotein Scientific Co (SHSE:688137) Headlines

No Headlines